Saran Saund serves as Executive at Oncotelic Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Saran Saund has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 8, 2021 involved receiving (via award) 102,519 shares valued at $0.
Saran Saund currently holds 16,457,480 shares of Oncotelic Therapeutics, Inc. (OTLC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Saran Saund has been a net neutral trader of OTLC stock. They have purchased $0 and sold $0 worth of shares.
Saran Saund's most recent insider trade was on Jul 8, 2021, when they sold 102,519 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |